In vitro studies using another Hsp90 inhibitor (RGRN-305) on psoriasis-like inflammatory response in human keratinocytes further confirmed the contribution of this chaperone to the development of psoriasis. The gene discussed is HSP90AA1; the disease is psoriasis.